GENinCode Plc (AIM:GENI)
London · Delayed Price · Currency is GBP · Price in GBX 1.800
0.00 (0.00%)
Aug 1, 2025, 4:35 PM GMT+1
Bally's Market Cap
GENinCode has a market cap or net worth of 5.16 million as of August 1, 2025. Its market cap has decreased by -48.81% in one year.
Market Cap
5.16M
Enterprise Value
4.29M
Revenue
2.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.80
Market Cap Chart
Since July 22, 2021, GENinCode's market cap has decreased from 40.72M to 5.16M, a decrease of -87.32%. That is a compound annual growth rate of -40.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.16M | -23.21% |
| Dec 31, 2024 | 6.72M | 33.68% |
| Dec 29, 2023 | 5.03M | -32.26% |
| Dec 30, 2022 | 7.43M | -76.15% |
| Dec 31, 2021 | 31.14M | -23.53% |
| Jul 22, 2021 | 40.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.24B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |